nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—CYP19A1—corpus luteum—testicular cancer	0.117	0.18	CbGeAlD
Nandrolone decanoate—AR—scrotum—testicular cancer	0.113	0.173	CbGeAlD
Nandrolone decanoate—CYP19A1—seminiferous tubule of testis—testicular cancer	0.0994	0.152	CbGeAlD
Nandrolone decanoate—AR—seminiferous tubule of testis—testicular cancer	0.088	0.135	CbGeAlD
Nandrolone decanoate—CYP19A1—semen—testicular cancer	0.055	0.0842	CbGeAlD
Nandrolone decanoate—Testicular atrophy—Chlorambucil—testicular cancer	0.0522	0.15	CcSEcCtD
Nandrolone decanoate—AR—semen—testicular cancer	0.0487	0.0746	CbGeAlD
Nandrolone decanoate—Oligospermia—Ifosfamide—testicular cancer	0.0239	0.0688	CcSEcCtD
Nandrolone decanoate—Azoospermia—Ifosfamide—testicular cancer	0.0186	0.0536	CcSEcCtD
Nandrolone decanoate—Azoospermia—Cisplatin—testicular cancer	0.016	0.0462	CcSEcCtD
Nandrolone decanoate—MAOB—embryo—testicular cancer	0.0117	0.0179	CbGeAlD
Nandrolone decanoate—Oligospermia—Methotrexate—testicular cancer	0.0113	0.0326	CcSEcCtD
Nandrolone decanoate—MAOB—seminal vesicle—testicular cancer	0.011	0.0168	CbGeAlD
Nandrolone decanoate—Local reaction—Bleomycin—testicular cancer	0.0106	0.0305	CcSEcCtD
Nandrolone decanoate—Oligospermia—Epirubicin—testicular cancer	0.0106	0.0305	CcSEcCtD
Nandrolone decanoate—AR—seminal vesicle—testicular cancer	0.0103	0.0158	CbGeAlD
Nandrolone decanoate—MAOA—embryo—testicular cancer	0.00996	0.0153	CbGeAlD
Nandrolone decanoate—Oligospermia—Doxorubicin—testicular cancer	0.00979	0.0282	CcSEcCtD
Nandrolone decanoate—MAOA—seminal vesicle—testicular cancer	0.00936	0.0143	CbGeAlD
Nandrolone decanoate—Azoospermia—Methotrexate—testicular cancer	0.0088	0.0253	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Chlorambucil—testicular cancer	0.00862	0.0248	CcSEcCtD
Nandrolone decanoate—CYP19A1—gonad—testicular cancer	0.00842	0.0129	CbGeAlD
Nandrolone decanoate—Azoospermia—Epirubicin—testicular cancer	0.00824	0.0237	CcSEcCtD
Nandrolone decanoate—Azoospermia—Doxorubicin—testicular cancer	0.00762	0.0219	CcSEcCtD
Nandrolone decanoate—AR—gonad—testicular cancer	0.00746	0.0114	CbGeAlD
Nandrolone decanoate—CYP19A1—female gonad—testicular cancer	0.00684	0.0105	CbGeAlD
Nandrolone decanoate—MAOB—female gonad—testicular cancer	0.00644	0.00987	CbGeAlD
Nandrolone decanoate—CYP19A1—testis—testicular cancer	0.00607	0.0093	CbGeAlD
Nandrolone decanoate—AR—female gonad—testicular cancer	0.00606	0.00928	CbGeAlD
Nandrolone decanoate—MAOB—testis—testicular cancer	0.00571	0.00875	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Ifosfamide—testicular cancer	0.0057	0.0164	CcSEcCtD
Nandrolone decanoate—Furunculosis—Methotrexate—testicular cancer	0.00558	0.0161	CcSEcCtD
Nandrolone decanoate—MAOA—female gonad—testicular cancer	0.0055	0.00842	CbGeAlD
Nandrolone decanoate—AR—testis—testicular cancer	0.00537	0.00823	CbGeAlD
Nandrolone decanoate—Furunculosis—Epirubicin—testicular cancer	0.00522	0.015	CcSEcCtD
Nandrolone decanoate—MAOA—testis—testicular cancer	0.00487	0.00747	CbGeAlD
Nandrolone decanoate—Furuncle—Methotrexate—testicular cancer	0.00483	0.0139	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—testicular cancer	0.00483	0.0139	CcSEcCtD
Nandrolone decanoate—Furuncle—Epirubicin—testicular cancer	0.00452	0.013	CcSEcCtD
Nandrolone decanoate—CYP19A1—lymph node—testicular cancer	0.0044	0.00674	CbGeAlD
Nandrolone decanoate—Furuncle—Doxorubicin—testicular cancer	0.00418	0.012	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Ifosfamide—testicular cancer	0.00416	0.012	CcSEcCtD
Nandrolone decanoate—MAOB—lymph node—testicular cancer	0.00414	0.00635	CbGeAlD
Nandrolone decanoate—Jaundice—Chlorambucil—testicular cancer	0.00413	0.0119	CcSEcCtD
Nandrolone decanoate—Fluid retention—Cisplatin—testicular cancer	0.0041	0.0118	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—testicular cancer	0.00401	0.0115	CcSEcCtD
Nandrolone decanoate—AR—lymph node—testicular cancer	0.0039	0.00597	CbGeAlD
Nandrolone decanoate—Local reaction—Doxorubicin—testicular cancer	0.00371	0.0107	CcSEcCtD
Nandrolone decanoate—MAOA—lymph node—testicular cancer	0.00353	0.00541	CbGeAlD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—testicular cancer	0.00325	0.00937	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—testicular cancer	0.00308	0.00886	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—testicular cancer	0.00301	0.00867	CcSEcCtD
Nandrolone decanoate—Irritability—Cisplatin—testicular cancer	0.00299	0.00862	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—testicular cancer	0.00285	0.0082	CcSEcCtD
Nandrolone decanoate—Dysphonia—Epirubicin—testicular cancer	0.0027	0.00776	CcSEcCtD
Nandrolone decanoate—Hypertension—Vinblastine—testicular cancer	0.00262	0.00754	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Epirubicin—testicular cancer	0.00252	0.00727	CcSEcCtD
Nandrolone decanoate—Dysphonia—Doxorubicin—testicular cancer	0.00249	0.00718	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—testicular cancer	0.00234	0.00672	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Ifosfamide—testicular cancer	0.00227	0.00653	CcSEcCtD
Nandrolone decanoate—Jaundice—Etoposide—testicular cancer	0.00216	0.00621	CcSEcCtD
Nandrolone decanoate—Urticaria—Chlorambucil—testicular cancer	0.00215	0.00618	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Methotrexate—testicular cancer	0.00212	0.00611	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—testicular cancer	0.00211	0.00606	CcSEcCtD
Nandrolone decanoate—Oedema—Bleomycin—testicular cancer	0.00209	0.00602	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Cisplatin—testicular cancer	0.00195	0.00563	CcSEcCtD
Nandrolone decanoate—Oedema—Dactinomycin—testicular cancer	0.00195	0.00562	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—testicular cancer	0.00195	0.00561	CcSEcCtD
Nandrolone decanoate—Pruritus—Chlorambucil—testicular cancer	0.00191	0.0055	CcSEcCtD
Nandrolone decanoate—Hypertension—Ifosfamide—testicular cancer	0.00189	0.00544	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—testicular cancer	0.00184	0.0053	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Etoposide—testicular cancer	0.00179	0.00516	CcSEcCtD
Nandrolone decanoate—Oedema—Ifosfamide—testicular cancer	0.00179	0.00515	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—testicular cancer	0.0017	0.00491	CcSEcCtD
Nandrolone decanoate—Urticaria—Bleomycin—testicular cancer	0.00166	0.00478	CcSEcCtD
Nandrolone decanoate—Irritability—Methotrexate—testicular cancer	0.00164	0.00473	CcSEcCtD
Nandrolone decanoate—Nausea—Chlorambucil—testicular cancer	0.00161	0.00462	CcSEcCtD
Nandrolone decanoate—Oedema—Cisplatin—testicular cancer	0.00154	0.00444	CcSEcCtD
Nandrolone decanoate—Hypertension—Etoposide—testicular cancer	0.00149	0.0043	CcSEcCtD
Nandrolone decanoate—Pruritus—Bleomycin—testicular cancer	0.00148	0.00426	CcSEcCtD
Nandrolone decanoate—Nausea—Vinblastine—testicular cancer	0.00147	0.00423	CcSEcCtD
Nandrolone decanoate—Urticaria—Ifosfamide—testicular cancer	0.00142	0.00409	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Methotrexate—testicular cancer	0.00137	0.00394	CcSEcCtD
Nandrolone decanoate—Rash—Bleomycin—testicular cancer	0.00132	0.0038	CcSEcCtD
Nandrolone decanoate—Dermatitis—Bleomycin—testicular cancer	0.00132	0.00379	CcSEcCtD
Nandrolone decanoate—Pruritus—Ifosfamide—testicular cancer	0.00126	0.00364	CcSEcCtD
Nandrolone decanoate—Nausea—Bleomycin—testicular cancer	0.00124	0.00358	CcSEcCtD
Nandrolone decanoate—Rash—Dactinomycin—testicular cancer	0.00123	0.00354	CcSEcCtD
Nandrolone decanoate—Jaundice—Epirubicin—testicular cancer	0.00121	0.00348	CcSEcCtD
Nandrolone decanoate—Nausea—Dactinomycin—testicular cancer	0.00116	0.00334	CcSEcCtD
Nandrolone decanoate—Rash—Ifosfamide—testicular cancer	0.00113	0.00324	CcSEcCtD
Nandrolone decanoate—Dermatitis—Ifosfamide—testicular cancer	0.00113	0.00324	CcSEcCtD
Nandrolone decanoate—Urticaria—Etoposide—testicular cancer	0.00112	0.00323	CcSEcCtD
Nandrolone decanoate—Jaundice—Doxorubicin—testicular cancer	0.00112	0.00322	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Methotrexate—testicular cancer	0.00107	0.00309	CcSEcCtD
Nandrolone decanoate—Nausea—Ifosfamide—testicular cancer	0.00106	0.00306	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—testicular cancer	0.001	0.00289	CcSEcCtD
Nandrolone decanoate—Pruritus—Etoposide—testicular cancer	0.000999	0.00288	CcSEcCtD
Nandrolone decanoate—Rash—Cisplatin—testicular cancer	0.000972	0.0028	CcSEcCtD
Nandrolone decanoate—Dermatitis—Cisplatin—testicular cancer	0.000971	0.00279	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000929	0.00267	CcSEcCtD
Nandrolone decanoate—Nausea—Cisplatin—testicular cancer	0.000915	0.00264	CcSEcCtD
Nandrolone decanoate—Rash—Etoposide—testicular cancer	0.00089	0.00256	CcSEcCtD
Nandrolone decanoate—Dermatitis—Etoposide—testicular cancer	0.000889	0.00256	CcSEcCtD
Nandrolone decanoate—Nausea—Etoposide—testicular cancer	0.000839	0.00241	CcSEcCtD
Nandrolone decanoate—Hypertension—Epirubicin—testicular cancer	0.000837	0.00241	CcSEcCtD
Nandrolone decanoate—Oedema—Epirubicin—testicular cancer	0.000791	0.00228	CcSEcCtD
Nandrolone decanoate—Hypertension—Doxorubicin—testicular cancer	0.000775	0.00223	CcSEcCtD
Nandrolone decanoate—Oedema—Doxorubicin—testicular cancer	0.000732	0.00211	CcSEcCtD
Nandrolone decanoate—Urticaria—Methotrexate—testicular cancer	0.000672	0.00193	CcSEcCtD
Nandrolone decanoate—Urticaria—Epirubicin—testicular cancer	0.000629	0.00181	CcSEcCtD
Nandrolone decanoate—Pruritus—Methotrexate—testicular cancer	0.000598	0.00172	CcSEcCtD
Nandrolone decanoate—Urticaria—Doxorubicin—testicular cancer	0.000582	0.00167	CcSEcCtD
Nandrolone decanoate—Pruritus—Epirubicin—testicular cancer	0.00056	0.00161	CcSEcCtD
Nandrolone decanoate—Rash—Methotrexate—testicular cancer	0.000533	0.00154	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methotrexate—testicular cancer	0.000533	0.00153	CcSEcCtD
Nandrolone decanoate—Pruritus—Doxorubicin—testicular cancer	0.000518	0.00149	CcSEcCtD
Nandrolone decanoate—Nausea—Methotrexate—testicular cancer	0.000502	0.00145	CcSEcCtD
Nandrolone decanoate—Rash—Epirubicin—testicular cancer	0.000499	0.00144	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—testicular cancer	0.000498	0.00144	CcSEcCtD
Nandrolone decanoate—Nausea—Epirubicin—testicular cancer	0.00047	0.00135	CcSEcCtD
Nandrolone decanoate—Rash—Doxorubicin—testicular cancer	0.000462	0.00133	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—testicular cancer	0.000461	0.00133	CcSEcCtD
Nandrolone decanoate—Nausea—Doxorubicin—testicular cancer	0.000435	0.00125	CcSEcCtD
